Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China flag China · Delayed Price · Currency is CNY
3.610
+0.200 (5.87%)
Aug 20, 2026, 3:04 PM CST

SHE:300026 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
1,5581,5021,3061,5741,2061,316
Cash & Short-Term Investments
1,5581,5021,3061,5741,2061,316
Cash Growth
31.24%15.00%-17.00%30.46%-8.34%16.89%
Accounts Receivable
2,5872,5722,8252,8923,5463,694
Other Receivables
29.433.6138.3450.0949.9459.23
Receivables
2,6162,6062,8642,9423,5963,753
Inventory
1,3211,3711,7491,9612,2141,305
Prepaid Expenses
-13.5512.513.2532.1116.77
Other Current Assets
239.62224.12217.18230.06336.93416.22
Total Current Assets
5,7355,7176,1496,7207,3856,806
Property, Plant & Equipment
2,9122,9533,1493,2423,3222,901
Long-Term Investments
178.36178.84235.58247.62244.03272.82
Goodwill
635.6635.6675.2692.54716.05716.05
Other Intangible Assets
258.83267.14298.45331.11352.73313.68
Long-Term Accounts Receivable
5.215.2126.3946.3794.1115.01
Long-Term Deferred Tax Assets
227.35223.41222.17129.29140.56108.16
Long-Term Deferred Charges
389.67393.54386.75402.6327.29311.53
Other Long-Term Assets
25.0218.0222.7723.1477.6862.51
Total Assets
10,36710,39211,16511,83512,66011,607

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
430.32449.97678.15713.45884.77605
Accrued Expenses
9.75268.52299.23184.08444.37519.36
Short-Term Debt
15.1314.8516.2423.18231.47293.79
Current Portion of Long-Term Debt
164.44116.65150.25167.67380.77100.02
Current Portion of Leases
-36.7545.2525.8855.0745.86
Current Income Taxes Payable
46.6510.2719.420.619.8215.12
Current Unearned Revenue
43.9752.0363.9776.27208.03137.56
Other Current Liabilities
509.99332.6348.67353.7463.6341.56
Total Current Liabilities
1,2201,2821,6211,5652,6782,058
Long-Term Debt
239.38260.59529.171,2571,3451,458
Long-Term Leases
97.08102.25111.1659.4278.1267.07
Long-Term Unearned Revenue
60.3262.0365.5662.5662.0467.55
Long-Term Deferred Tax Liabilities
29.9831.2839.5223.233.813.95
Total Liabilities
1,6471,7382,3672,9674,1973,655

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
3,0043,0043,0043,0043,0043,004
Additional Paid-In Capital
589.89589.89589.89589.49589.49589.49
Retained Earnings
5,0374,9715,0435,1124,6954,199
Comprehensive Income & Other
-51.55-48.796.834.750.86-19.98
Total Common Equity
8,5808,5178,6448,7108,2907,773
Minority Interest
140.59137.68154.66157.7172.87179.49
Shareholders' Equity
8,7208,6548,7998,8688,4637,952
Total Liabilities & Equity
10,36710,39211,16511,83512,66011,607

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
516.04531.1852.071,5332,0911,965
Net Cash (Debt)
1,042971.06454.1240.24-884.45-648.87
Net Cash Growth
109.01%113.83%1028.45%---
Net Cash Per Share
0.540.530.210.01-0.30-0.22
Filing Date Shares Outstanding
3,0043,0043,0043,0043,0043,004
Total Common Shares Outstanding
3,0043,0043,0043,0043,0043,004
Working Capital
4,5154,4354,5285,1554,7074,748
Book Value Per Share
2.862.832.882.902.762.59
Tangible Book Value
7,6857,6147,6707,6867,2216,743
Tangible Book Value Per Share
2.562.532.552.562.402.24
Buildings
-2,0001,9861,9881,7301,651
Machinery
-2,5522,5442,5142,1551,852
Construction In Progress
-130.89104.1954.11461.01232.93